Genetic dissection of an amygdala microcircuit that gates conditioned fear by Haubensak, Wulf et al.
Genetic dissection of an amygdala microcircuit that gates
conditioned fear
Wulf Haubensak1, Prabhat Kunwar1,*, Haijiang Cai1,*, Stephane Ciocchi3,*, Nicholas Wall4,
Ravikumar Ponnusamy5, Jonathan Biag6, Hong-Wei Dong6, Karl Deisseroth7, Edward M.
Callaway4, Michael S. Fanselow5, Andreas Lüthi3, and David J. Anderson1,2,8
1Division of Biology 216-76, California Institute of Technology, Pasadena, CA USA 91125
2Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA USA 91125
3Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland 4Systems
Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037
5Department of Psychology and the Brain Research Institute, University of California, Los
Angeles, Los Angeles, CA 90095 6Laboratory for Neuroimaging, University of California, Los
Angeles, Los Angeles, CA 90095 7Department of Bioengineering, Stanford University, Stanford,
CA 94305
Abstract
The role of different amygdala nuclei (neuroanatomical subdivisions) in processing Pavlovian
conditioned fear has been studied extensively, but the function of the heterogeneous neuronal
subtypes within these nuclei remains poorly understood. We used molecular genetic approaches to
map the functional connectivity of a subpopulation of GABAergic neurons, located in the lateral
subdivision of the central amygdala (CEl), which express protein kinase C-delta (PKCδ).
Channelrhodopsin-2 assisted circuit mapping in amygdala slices and cell-specific viral tracing
indicate that PKCδ+ neurons inhibit output neurons in the medial CE (CEm), and also make
reciprocal inhibitory synapses with PKCδ− neurons in CEl. Electrical silencing of PKCδ+ neurons
in vivo suggests that they correspond to physiologically identified units that are inhibited by the
conditioned stimulus (CS), called CEloff units (Ciocchi et al, this issue). This correspondence,
together with behavioral data, defines an inhibitory microcircuit in CEl that gates CEm output to
control the level of conditioned freezing.
The amygdala is a medial temporal lobe region that plays a central role in the acquisition
and expression of Pavlovian conditioned fear1-3. The amygdala contains multiple
anatomically defined nuclei4. Associative learning largely occurs in the lateral nucleus (LA),
while the central nucleus (CEA) is thought to control the expression of fear5,6. However
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CEA contains at least 3 subnuclei (CEm, CEl and capsular CE)3,4 and multiple neuronal
subtypes7-10, the role of which is poorly understood. A full understanding of amygdala
function requires its dissection at the cellular level.
Here we have used genetic methods to investigate the functional connectivity and behavioral
relevance of a GABAergic subpopulation within CEl11-13, marked by expression of protein
kinase C-δ (PKCδ). These neurons inhibit output neurons in CEm, and also make reciprocal
inhibitory connections with PKCδ− neurons within CEl. Genetic silencing14,15 in
conjunction with in vivo electrophysiology indicates that these neurons likely correspond to
“CEloff” units identified by Ciocchi et al.16, that are inhibited by the conditioned stimulus
(CS). Taken together, these data define the functional connectivity and behavioral relevance
of an inhibitory microcircuit within CEl9,17, that gates output from CEm12.
Properties of PKCδ+ neurons in CEl
We sought stable markers for CEA subpopulations18,19, which could be used to genetically
manipulate their activity in vivo20-22. PKCδ marks ∼50% of CEl GABAergic neurons (Fig.
1a-d and Table S1). These neurons are distinct from those expressing corticotropin releasing
hormone9 (CRH; Fig. 1e-g) or dynorphin10 (Dyn; Fig. S1a-c), while ∼40% express
enkephalin9 (Enk; Fig. 1h-j and Table S1) and ∼65% express the oxytocin receptor (OxtR;
Fig. S1d-f and Table S1), which is implicated in inhibitory gating of CEm12.
We examined the electrophysiological properties of PKCδ+ neurons in acute amygdala
slices. Due to their low spontaneous activity, spiking was evoked by injection of
depolarizing current. This analysis confirmed three types of neurons: late-firing, regular
spiking, and low-threshold bursting neurons23 (Fig. 1k, l and Table S2). Neurobiotin fills
and antibody staining, as well as recording from fluorescently labeled PKCδ+ neurons in
transgenic mice (see below) indicated that most PKCδ+ neurons are late-firing (Fig. 1m, o
and Table S3), while the PKCδ- population contains both regular spiking and late-firing
units (Fig. 1n, o and Table S3). Thus, PKCδ+ neurons have relatively homogeneous
electrophysiological properties (Table S4, P < 0.0001, Fisher's Exact Test).
Functional connectivity of PKCδ+ neurons
To gain genetic access to PKCδ+ neurons, transgenic mice were generated24 harboring a
bacterial artificial chromosome (BAC) expressing Cre recombinase and the alpha subunit of
a CFP-tagged version of the C. elegans glutamate-sensitive chloride channel GluCl25 (Fig.
2a), separated by an internal ribosome entry site (ires)26. Double-labeling for GluClα-CFP
and PKCδ in these PKCδ:GluClα-ires-Cre mice, as well as crossing to Cre-dependent lacZ-
expressing reporter mice, revealed neuron-specific expression of the transgene (Fig. 2j-m)
that correctly recapitulated the pattern of endogenous PKCδ expression (Fig. 2b-e, f-i).
CEl is known to contain GABAergic neurons that project to CEm7,12,27,28. We traced the
anterograde projections of PKCδ+ neurons to CEm by injecting the CEl of the transgenic
mice with a Cre-dependent adeno-associated virus (AAV) encoding humanized renilla
GFP29 (hrGFP) (Fig. 3a-j). Recombination of injected AAVs was restricted to PKCδ+
neurons (Fig. S2f-j). hrGFP+ fibers derived from CEl projected to CEm (Fig. 3h, inset) (Fig.
3i, j), a result confirmed by retrograde tracing from CEm using cholera toxin B-subunit
(CTB) (Fig. 3k, l). 60.9±5.7% (mean±S.E.M., n = 6) of CTB+ neurons in CEl were PKCδ+
(Fig. 3m-o, inset white arrowhead), while the remainder were PKCδ−.
Freezing is controlled by projections from CEm to the peri-aqueductal gray (PAG)30-32, but
CEm contains multiple neuronal subpopulations with different connectivities32. To
determine whether PKCδ+ neurons make inhibitory synapses onto PAG-projecting CEm
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output neurons, we combined whole-cell patch clamp recording of retrogradely-labeled
CEm output neurons, with Cre-dependent optogenetic activation33 of PKCδ+ neurons (Fig.
3p, q), in acute amygdala slices. Selective expression of channelrhodopsin-2 (ChR2)34 in
PKCδ+ neurons was achieved by injecting a Cre-dependent AAV encoding ChR2-YFP35
into the CEl of PKCδ:GluClα-ires-Cre transgenic mice (Fig. S9a). Whole-cell patch-clamp
recordings from ChR2-expressing PKCδ+ neurons (identified using native fluorescence for
YFP (ChR2) and CFP (GluClα; Fig. S9b)) confirmed that spiking could be induced with
∼90% efficiency using 473 nm light flashes at 15 Hz (Fig. S9g). Retrograde labeling of
CEm projection neurons in the same animals was achieved by injection of Alexa-555-
conjugated CTB into the PAG (Fig. 3p), permitting their prospective identification using
native fluorescence (Fig. 3q, CTB, arrowhead).
In slices prepared from dually injected animals, optogenetic activation of CEl PKCδ+
neurons elicited robust, picrotoxin-sensitive IPSCs in CEm output neurons (success rate
100%) (Fig. 3r, s; IPSC amplitude, 18.3±2.3 pA, n = 6 cells), with an average latency =
3.7±0.2 ms (range 2-5 ms, n = 30) and mean temporal jitter = 0.83±0.16 ms (n = 6),
consistent with monosynaptic transmission36. It also suppressed current injection-evoked
action potentials in CEm output neurons (Fig. 3t, v), in a picrotoxin-sensitive manner (Fig.
3u, w). Thus, CEl PKCδ+ neurons make inhibitory connections onto PAG-projecting CEm
output neurons.
Light-activation of ChR2-expressing PKCδ+ neurons also evoked monosynaptic IPSCs, and
suppressed current injection-evoked action potential firing, in CEl PKCδ− neurons
(identified by the absence of CFP fluorescence), in a picrotoxin-sensitive manner (Fig. 4a-
g). Therefore, PKCδ+ neurons also make local inhibitory connections within CEl onto
PKCδ− neurons.
To determine whether, conversely, PKCδ+ neurons receive inhibitory input from PKCδ-
neurons, we employed a cell-specific modification of a virally based mono-synaptic
retrograde tracing method37. PKCδ∷GluClα-ires-Cre transgenic mice were first injected
with a Cre-dependent AAV encoding both an avian receptor, TVA, and a complementing
RV-G protein deleted from the rabies virus strain RVΔG (Fig. 4h, left)38. Three weeks later,
animals were injected in the same site with Env(A)-pseudotyped RVΔG virus expressing the
red fluorescent protein mCherry (Fig. 4h, right; see Methods). Since Env(A) directs
infection exclusively to TVA-expressing cells37, this manipulation yields expression of
mCherry in CEl PKCδ+ neurons in transgenic (Fig. 4m-p; inset, open arrowheads), but not
wild-type (Fig. 4i, j) mice. Expression of G by AAV-infected PKCδ+ neurons permits trans-
synaptic spread of the RVΔG virus to input neurons, but no further spread occurs37.
Monosynaptic retrograde labeling of PKCδ− neurons occurred extensively in CEl (Fig. 4m,
n, p; inset, filled arrowheads), and most labeled neurons were GABAergic (Fig. 4q-t; inset,
arrowhead). These data suggest that PKCδ+ neurons receive inhibitory input from PKCδ-
neurons.
PKCδ+ neurons correspond to CEloff units
Single-unit recording experiments in freely behaving mice have identified two types of CEl
units with opposite responses to the CS16: units activated by the tone (“CElon” cells), and
units inhibited by it (“CEloff”) cells (Fig. 5i-l). We wished to determine whether PKCδ+
neurons correspond to either of these classes of units. As the in vivo recordings employ
extracellular electrodes16, the cells cannot be filled for antibody staining. Therefore, we
examined the effect of reversibly silencing PKCδ+ neurons on the activity of CElon and
CEloff units, using a mammalian codon-optimized form39 of the IVM-sensitive chloride
channel GluCl from C. elegans14,15, mutated to eliminate glutamate sensitivity25. Functional
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expression of this ionotropic receptor requires two subunits: GluClα and GluClβ. To restrict
expression of GluClαβ to CEl PKCδ+ neurons, we employed an intersectional strategy in
which GluClα–CFP was expressed transgenically in all PKCδ+ neurons (Fig. 2b), while
GluClβ-YFP25 was expressed in CEl from an AAV vector by stereotaxic injection (Fig. 5a;
S2a-e).
We first confirmed silencing of PKCδ+ neurons using IVM/GluCl in acute amygdala slices
from such mice. Neurons expressing GluClα and/or GluClβ could be prospectively
identified by native CFP and YFP fluorescence, respectively (Fig. 5c-e). Bath application of
IVM reduced the input resistance of cells expressing GluClαβ, but not of cells expressing
either GluClα or GluClβ, from 337±41 to 277±36 MΩ (n = 4, P < 0.04, paired t-test). IVM
also significantly suppressed current injection-evoked spiking in neurons co-expressing both
subunits (Fig. 5c-h), as well as sub-threshold EPSPs evoked by bipolar electrode stimulation
of LA (Figure S3; such bipolar stimulation did not evoke spiking of PKCδ+ neurons in our
slice preparation).
We next examined the effect of silencing PKCδ+ neurons on CElon and CEloff unit
activity16, in PKCδ∷GluClα-ires-Cre transgenic mice previously injected in CEl with the
AAV∷GluClβ virus. CElon and CEloff units were first identified by CS presentation in
conditioned animals, prior to IVM administration. The spontaneous spiking activity of these
units was subsequently measured before, and 3-5 days after, IVM administration. The tonic
activity of CEloff units was strongly suppressed following IVM treatment, while that of
CElon units was unaffected (Fig. 5m, n). This effect of IVM reversed within 48 hrs after
treatment (Fig. 5m), and was not observed in IVM-treated uninjected transgenic animals, or
in virally injected animals not treated with IVM (Fig. 5n). Importantly, silencing PKCδ+
neurons by IVM/GluCl also increased CEm unit activity (Fig. 5m, n red symbols),
consistent with our observation that PKCδ+ CEl neurons inhibit CEm output neurons (Fig.
3q-w). The simplest interpretation of these data is that CEloff units are PKCδ+ neurons,
although this does not necessarily imply the converse.
Finally, we tested the effect of suppressing PKCδ+ neuronal activity on fear conditioning
(see Methods). Because of the slow decay kinetics of IVM in vivo14, we initially
investigated the effect of silencing during both training and testing. While IVM at the dose
used (10 mg/kg) did not significantly affect freezing in wild-type animals (Fig. S4a), to
avoid potential interactions between IVM treatment and viral infection, in most experiments
single subunit-expressing control animals (transgenic or wild-type animals injected with
GluClα or GluClβ virus, respectively) were also treated with IVM. These control groups
were not significantly different from each other (Fig. S4b) and were pooled for statistical
analysis.
In some experiments (n=5-8 animals/group), using a high-titer (1013/ml) preparation of
AAV2:GluClβ14, a significantly higher level of freezing was observed in experimental
animals than in controls; however in other such experiments using different virus
preparations, no difference between groups was detected (Supplementary Footnote 1).
Quantitative histological analysis (Fig. S10) revealed considerable variation in the level and
bilaterality of GluClβ-YFP expression among individual animals (Fig. S5a-c). Therefore,
data from multiple experiments (total n=54 animals/group) were pooled for statistical
analysis. A Randomized Block ANOVA40 with 6 experimental and 6 control subjects
assigned to each of 9 blocks based on infection rate (total n=108; Table 5 and Fig. S5d-f)
indicated a significant block × group interaction during both the CS presentation (F(8, 90) =
2.298, P<0.05 by post-hoc Bonferroni t-test) and post-CS periods (F(8, 90) = 2.459, P < 0.05),
but not the baseline (BL) period (F(8,90) = 1.41, P = 0.205). Freezing was significantly
higher in the experimental group only in the block with the highest infection rate (Table I,
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Table S5 and Fig. S5e, f). Freezing in the experimental group was also significantly higher
than controls (including GluClαβ animals tested without IVM; n=6) among animals
expressing GluClbeta; bilaterally in CEA at a level above the median infection rate (Fig.
S7). There was no significant decrease in baseline locomotor activity, or in the activity burst
produced by the first US presentation during training (Fig. S8) in experimental animals,
indicating that the increased freezing is not a consequence of either decreased locomotor
activity, or increased US-sensitivity13. Freezing levels during the pre-training and pre-test
baseline were unaffected by IVM in experimental animals (Table S5, Figs. S5 and S7 and
data not shown).
Discussion
We have used genetically based methods to investigate the functional connectivity of a
subpopulation of CEl GABAergic neurons identified by expression of PKCδ. Our data
suggest that these neurons participate in a recurrent inhibitory circuit within CEl that inhibits
CEm output to brainstem centers that control freezing, consistent with earlier
suggestions9,12. In the accompanying paper16, Ciocchi et al. identify two populations of CEl
units in vivo with opposite responses to the CS. The data presented here strongly suggest
that CEloff units are PKCδ+ neurons, linking molecular and physiological identity. Because
PKCδ+ neurons pre-exist in untrained animals, this linkage suggests that CEloff and CElon
units, which are robustly identifiable after conditioning (Fig. 5k, l), arise via plasticity-
dependent changes in deterministic CEl subpopulations, rather than by stochastic selection
from a population of initially homogeneous cells.
The link between PKCδ+ neurons and CEloff units is also consistent with complementary
connectivity data in the two studies. For example, Ciocchi et al. have shown that in vivo, the
activity of CEloff units is inversely correlated with the activity of CElon units, suggesting
reciprocal inhibition16. Our channelrhodopsin-assisted circuit mapping36 and cell-specific
monosynaptic retrograde viral tracing37 data directly demonstrate mutual inhibitory
connections between PKCδ+ and PKCδ− neurons in CEl. Ciocchi et al. have also shown that
CS exposure both inhibits CEloff unit spiking, and increases CEm unit activity16, with a
short latency implying an inhibitory connection. Our data directly demonstrate inhibitory
synapses from CEl PKCδ+ neurons onto brainstem-projecting CEm output neurons, and
indicate that silencing the former increases the tonic activity of the latter in vivo. Thus, our
direct mapping of PKCδ+ synaptic connectivity in amygdala slices is consistent with
inferences of CEloff unit connectivity based on correlative in vivo recordings (Fig. 5b).
Consistent with these electrophysiological and connectional data, genetic silencing of
PKCδ+ neurons yielded a statistically significant enhancement of conditional freezing
(during both the CS-on and post-CS periods), among those animals exhibiting the highest
level of AAV∷GluClβ infection in CEl. Nevertheless, these behavioral results should be
interpreted with caution, given the variability in results between individual experiments (see
Supplementary Footnote 1). Furthermore, while IVM treatment caused a decrease in CEloff
tonic spiking activity in GluClαβ -expressing animals, how this effect influences CS-evoked
freezing, which is correlated with phasic CS-response in CEloff unit activity16, is not yet
clear.
While the CEl circuitry defined by this study and Ciocchi et al.16 is remarkably consistent,
the behavioral results in the two studies differ in some respects. For example, muscimol
injection into CEl evoked freezing in unconditioned animals16, while selective silencing of
PKCδ+ neurons using IVM/GluCl did not. Furthermore, transient inhibition of CEl during
training using muscimol attenuated fear conditioning16, while chronic silencing of PKCδ+
neurons during both training and testing did not. We have not yet examined the behavioral
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effects of silencing PKCδ+ neurons during training vs. testing, and this will be an important
question for future studies. Differences in the consequences of muscimol inhibition of CEl
vs. IVM/GluCl silencing of CEl PKCδ+ neurons may reflect differences in the cellular
specificity, efficiency or time-course of the two types of manipulations (Supplementary
Footnote 2).
The CEl/CEm micro-circuit revealed by these companion studies has interesting properties
worthy of further investigation. For example, the mutual inhibitory connections between
CEloff and CElon units could provide a positive-feedback loop to amplify CS-evoked activity
in CElon units (Fig. 5b)41. These antagonistic connections could also potentially encode
different states, through stable imbalances in tonic activity16, or different oscillatory
regimes, that could influence the learning and/or expression of conditioned fear. A currently
unresolved paradox is why, if CElon units (like CEloff units) send inhibitory projections to
CEm16, activation of CElon units by the CS results in increased rather than decreased
activity of CEm output neurons (see Supplementary Footnote 3). Resolution of this paradox
will require distinguishing whether these two CEl populations target the same or different
classes of CEm neurons32, and the relative strength of these connections. Genetically based
synaptic tracing and functional manipulations of CElon units should clarify this issue, as well
as provide direct tests of their causal role in conditioned freezing and other emotional
behaviors. The ability to prospectively identify and selectively manipulate PKCδ+ and other
molecularly defined CEl subpopulations42,43 should also open the way to investigating their
roles in animal models of phobic or anxiety disorders, and in the mechanism of action of
drugs used to treat such disorders44.
Methods Summary
Histochemical methods
Single color and double fluorescent ISHs were performed on fresh frozen sections, using
DIG (Roche) and DNP (Perkin Elmer) labeled RNA probes. Immunofluorescence was
carried out on cryosections of 4 % PFA perfused tissue following standard protocols.
Generation of PKCδ∷GluClα-ires-Cre transgenic mice
A GluClα-ires-Cre cassette was inserted into PKCδ BAC clone RP23-283B12 (CHORI).
The modified BAC was injected into FVB mouse embryos (GENSAT). Transgenic founders
were backcrossed (n > 5) to C57Bl6/N. These mice are available through GENSAT24.
Pharmacogenetic silencing in vitro and in vivo
PKCδ∷GluClα-ires-Cre transgenic or wild-type mice were injected with ∼109 particles of
AAV∷GluClβ (or, in control experiments, AAV∷GluClα) into CE and allowed 4 weeks for
recovery. For fear conditioning experiments, on day 1, mice were habituated and then
injected with IVM (10 mg/kg (Phoenix)). On day 2, animals received tone/foot shock
pairings in context A (Coulbourn, Med Associates). On day 3, (and for in vivo recordings
also on days 6 and 8), animals were placed in context B and freezing was scored prior to
(baseline), during and after CS presentations. For in vitro recordings, acute brain slices were
prepared and superfused with 20 nM IVM in ACSF to induce pharmacogenetic silencing.
Single-unit recordings were performed in freely behaving animals as described16.
Optogenetic circuit dissection
PKCδ∷GluClα-ires-Cre transgenic mice were injected with 109 particles of Cre-dependent
ChR2 AAV into CE, and (in some animals) CTB into PAG for retrograde labeling. Four
weeks later, neurons were light-stimulated, in acute brain slices, through a 200 μm optical
fiber (Thorlabs) emitting 5-10 mW 473 nm laser light (Crystalaser).
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Virus based transsynaptic tracing
PKCδ∷GluClα-ires-Cre transgenic mice were sequentially injected into CE with 104
particles of AAV encoding Cre-dependent TVA and rabies B19 glycoprotein (G). Three
weeks later, animals were injected in the same site with 105 particles of RVΔG rabies virus
pseudotyped with EnvA, and analyzed 1 week later. All animal experiments were conducted
under protocols approved by the Caltech Institutional Animal Care and Use Committee
(IACUC) and the Salk Institute Biosafety Committee.
Methods
Generation of PKCδ∷GluClα-iCre transgenic mice
The PKCδ∷GluClα-iCre targeting construct was assembled in pGEM-T Easy (Promega) by
PCR-cloning nucleotides -425 to -1 (+1 corresponding to the PKCδ start codon, primer set
5′-ACACACCGCGGCGCGCCCTAAAGAGGCAGGAGGCATGTG and 5′-
CCATGATGGAGCCTGGAGTGAG) and +4 to +561 (primer set 5′-
TCTCTGCTAGCCCGGGACCCTTCCTGCGCATCTC and 5-
TGTGTGGTCGACTTAATTAAACTAGTGACCTTTCCAGCCATCACGTG) of PKCδ
genomic sequences 5′ and 3′ to the GluCl-α open reading frame (ORF)39, using Ksp I-
blunt/Mlu NI and Nhe I-Sal I restriction sites, respectively. The resulting PKCδ∷GluClα
cassette was then cloned into the pLD53 shuttle vector 45. An additional expression cassette
containing the Encephalomyocarditis virus internal ribosome entry site (IRES) followed by
an ORF coding for Cre-recombinase was cloned into the Nhe I site immediately downstream
GluClα. This vector was then used to introduce the GluClα-iCre expression cassette into a
bacterial artificial chromosome (BAC) clone containing the complete PKCδ gene
(RP23-283B12) by Rec A-mediated homologous recombination in bacteria 45 (for final
sequence see Supplementary Information). Homologous recombination was verified by PCR
(5′ arm primer set 5′-AGACCAGGGTAGGAGTCGGTG and 5′-
GATCAGGGAAGCGATGATCAG, 3′ arm primer set 5′-
GAGACCAAGACCGAGTGGAA and 5′-CACAGGTTAGCCATGACCTG) and southern
blotting (5′ arm probe primer set 5′-TGTTCATGGGGTTTCTCACAG and 5′-
ACCGACTCCTACCCTGGTCAG, 3′ arm probe primer set 5′-
AGGTCATGGCTAACCTGTGG and 5′-GGCAGAGAAGTCAGACTGGG). Transgenic
mice were generated by pronuclear injection of CsCl prepared BAC DNA linearized with P-
Sce I in FVB embryos 24, which yielded two independent transgenic lines with
indistinguishable expression pattern. One of them was backcrossed for n>5 generations to
C57Bl6/N. Germ line transmission and genotyping of transgenic offspring were traced by
PCR on genomic tail DNA (primer set 5′- GCTACATCAAGGCCATCGAC and 5′-
AACTCCAGCAGGACCATGTGATCG).
In situ hybridizations
ISH was performed on 20 μm fresh frozen brain sections.
Processing of sections, hybridization and probe detection for single color in situ
hybridizations were carried out following standard protocols 19, with the following
specifications: Probes were cloned from whole mouse brain cDNA library (Invitrogen;
GAD65 primer set 5′-ATCTCCAACATGTATGCCATGCTCATTGCC and 5′-
TTACAAATCTTGTCCGAGGCGTTCGA, CRH primer set 5′-
AACGGAGTAAGGGCAGGAATGGAGACAGAG and 5′-
GTTGCTGTGAGCTTGCTGAGCTAACTGCTCTGC, Enk primer set 5′-
TAGGGTCCAAGCTCTCATTGAGGCACCCGG and 5′-
GCTTCAGAACCGCATAAAGCCCCCGTAT, OxtR 5′-
CTGGCCCACCAGGCCAGCCGCTGGGTGGTG and 5′-
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AATCCCCATCTCCTTGGGAATTTTAGGAT) transcribed from linearized templates in
pTeasy (Promega) or pCR2.1 (Invitrogen) using Sp6 (9PIP108, Promega) or T7 (9PIP207,
Promega) polymerase and Digoxigenin labeled nucleotide mix (11277073910, Roche), used
at a final concentration of 1 μg/ml, and detected with Anti-Dig-HRP, Fab fragments
(1-207-733, Roche).
Processing of sections and hybridization for double fluorescence ISH was carried out as
above, with the following specifications: DIG and DNP-UTP (NEL555001, Perkin Elmer)
probe pairs were used at a final concentration of 1 μg/ml each. For detection, sections were
blocked first in 20 % sheep serum in 0.1M Tris-HCl, pH7.5, 0.15M NaCl, 0.05% Tween-20
and NEN-Blocking solution (Perkin Elmer) for 30 min, each. DIG labeled probe was
detected with anti-DIG Horseradish peroxidase (POD) (1: 500, 2h), Biotin-Tyramide (1:100,
8 min, RT, Perkin Elmer), Vecta Stain Elite ABC Kit (Vector PK-6100) and Cy3-Tyramide
(Cy3 Tyramide NEL704A, PerkinElmer, 1: 50, 1h). Horseradish peroxidase was inactivated
by incubation in 3 % H2O2 in PBS (1 h), followed by heat denaturation in TE (5 min, 85 C).
Sections were blocked again as above and DNP-labeled nucleotides were detected with anti-
DNP Horseradish peroxidase (1:500, 2h), DNP-Tyramide, anti-DNP Horseradish peroxidase
(1:500, 2h, all TSA DNP Kit, NEL747A, PerkinElmer) and Fluorescein-Tyramide (1: 100,
NEL701, PerkinElmer). Sections were mounted in Fluoro Gel (17985-10, Electron
Microscopy Sciences). All washing steps and incubations were carried out according to the
respective manufacturers' recommendations. Sections were visualized on Zeiss Axioscope,
and Leica TCS SP confocal, microscopes.
Immunofluorescent labelling
For IFL, mice were transcardially perfused with 4 % paraformaldehyde in PBS. Brains were
removed and cryoprotected in 15 % sucrose (16 h, 4 C). 20-30 μm cryo-sections were air
dried for 30 min, rehydrated in PBST (PBS + 0.1 % Trition-X-100). In some instances,
immunoreactivity was increased by incubating the slides in 10 mM Sodium citrate, 0.05 %
Tween-20, pH 6 for 10 min at 95 C. Non-specific binding was blocked with 1 % BSA in
PBST for 30 min. Primary antibodies, diluted 1:300-1000 in blocking solution (mouse anti
PKCδ, 610398 BD Biosciences; Guinea Pig anti Dynorphin, GP10110 Neuromics; rabbit
anti GFP A11122, Invitrogen; rabbit anti hrGFP 240142, Stratagene; Mouse anti NeuN
MAB377, Chemicon) were incubated at for 16 h at 4 °C. Standard secondary antibodies
(Invitrogen) in blocking solution were incubated for 3 h at RT. Unbound primary and
secondary antibody was each washed by incubating three times in PBST for 10 min.
Sections were mounted in Fluoro Gel (17985-10, Electron Microscopy Sciences) and
visualized on Zeiss Axioscope, and Leica TCS SP confocal, microscopes.
Animal Maintenance
Animals were group housed at 23 C with ad libitum access to food and water in a 13 h day,
11 h night cycle, day starting at 7 AM.
Histological analysis
All histological quantifications (Fig. 2i, m, S2e, j, S5, S7, S10 and Tables S1, S5) are based
on at least three coronal sections spaced equidistantly along the rostro-caudal axis of CE.
The intrinsic fluorescence of GluClα−CFP, or GluClβ-YFP can be readily detected in live
brain slices (Fig. 4a, 5c-e, S9a, b). In the perfusion fixed tissue used for all histological
analysis, however, the fluorescent signal is substantially weaker. Therefore, GFP IFL
directed against its C/YFP tag was used wherever possible for more accurate results (Fig.
1b-h, 1j-l, S2b-d, S5). However, this immunohistochemical method could not be used to
quantify the extent of infection by AAV∷GluClβ-YFP in PKCδ∷GluClαCFP-iCre
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transgenic mice, because of cross-reactivity of the anti-GFP antibody with the transgene-
encoded CFP. Therefore, the fraction of virally infected PKCδ+ neurons in
PKCδ∷GluClαCFP-iCre transgenic brains was estimated by quantifying the number of cells
expressing intrinsic YFP fluorescence (which could be spectrally distinguished from the
endogenous CFP-fluorescence of the GluClα transgene). However, because this intrinsic
fluorescence signal underestimates the extent of viral infection in perfusion-fixed tissue (see
above), we constructed a standard curve using wild-type mice infected with AAV:GluClβ-
YFP virus, in which the number of infected cells measured using native YFP fluorescence
was plotted against the number of infected PKCδ+ cells measured using double-
immunofluorescence staining with anti-GFP and anti-PKCδ antibodies (Fig. S10). This
standard curve was then used to estimate the fraction of PKCδ+ cells that would have been
detectable by direct immunofluorescence labeling for GFP, based on quantification of native
YFP fluorescence. In the behavioral experiments in which wild-type and PKCδ∷GluClα-
CFP-iCre transgenic animals were classified based on their infection rates (Table S5, Table
I, Fig. S5, S7), this estimation method was applied to all experimental groups, including
wild-type animals.
Electrophysiological slice recordings
Standard mouse brain slice preparation and whole cell recording were performed as
described14. Briefly, 250 μm thick coronal sections were prepared with a vibratome
(VT1000S, Leica), using ice-cold glycerol-based artificial cerebrospinal fluid (gACSF, in
mM: 252 glycerol, 1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 18 NaHCO3, and 11
glucose, oxygenated with 95%O2/5%CO2). Slices were allowed to recover for at least 1
hour at 32°C and kept at room temperature in standard artificial cerebrospinal fluid (ACSF,
in mM: 126 NaCl, 1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 18 NaHCO3, and 11
glucose, oxygenated with 95%O2/5%CO2). Cells expressing CFP or YFP were visualized by
infrared DIC and fluorescence video microscopy (Olympus BX51). Whole-cell voltage and
current recordings were performed at 30 °C with a MultiClamp 700B amplifier and Digidata
1440A (Molecular Devices, Sunnyvale, CA). The patch pipette with a resistance of 5-8 MΩ
was filled with an intracellular solution containing (in mM): 135 Potassium gluconate, 5
EGTA, 0.5 CaCl2, 2 MgCl2, 10 HEPES, 2 Mg-ATP, and 0.1 GTP, PH 7.2, 280-300 mOsm.
Data were sampled at 10 kHz, filtered at 3 kHz and analyzed with pCLAMP 10 software.
Electrophysiological characterization of PKCδ+ cells
The relation of genetic marker and electrophysiological type was analyzed using Fisher's
exact test with the null hypothesis that PKCδ+ cells have the same proportion of late-firing
neurons as do CEl neurons as a whole. We recorded 38 CEl neurons without knowing their
genetic subtypes, 21 of which were late-firing neurons. 14 of the17 non late-firing neurons
were regular-spiking, 3 low-threshold bursting cells (Table S2, S3). We also recorded 57
PKCδ+ neurons based on their CFP expression, and found 49 of them are late-firing
neurons, 8 of them are non late-firing neurons (all 8 cells are regular-spiking cells; Table
S4). Fisher's exact test revealed that PKCδ+ neurons have a relatively homogeneous
electrophysiological property of late-firing neurons compared to CEl neurons as a whole.
Stereotaxic surgery
2-4 months old male mice were deeply anesthetized with either ketamine/xylazine or
isoflurane, injected i. p. with 500 μl 20 % mannitol (Phoenix pharmaceuticals), and placed
in a stereotaxic frame (Kopf). The skull was exposed and perforated using a stereotaxic
mounted drill at the desired coordinates (Table S6). For post-operative care mice were
injected i. p. with 2 mg/kg BW ketoprofen, and supplied with drinking water containing 80
mg/l Trimethoprim, 400 mg/l sulfamethoxazole and 200 mg/l Ibuprofen for 10 days.
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Viral injections
Viral particles were delivered unilaterally by stereotaxic (see above) injection with through
stereotaxic mounted motor driven 32 G 45 degree beveled steel cannulas (Micro 4 controller
equipped with Hamilton system, World Precision Instruments) or glass capillaries (Micro4
controller equipped with Microject system, Word Precision Instruments) to 1-4 injection
sites/hemisphere at flow rates of 50-100 nl/min.
Pharmacogenetic silencing in vitro
Mice were unilaterally injected with a total of 2 μl AAV GluClα or -β virus (serotype 2;
1-10 × 1012 particles/ml in PBS) into CE (see above). Four weeks after surgery, slices (see
above) were perfused with 20 nM IVM in ACSF for 20 min to induce pharmacogenetic
silencing.
Pharmacogenetic silencing in vivo
Mice were injected bilaterally with a total of 2 μl AAV GluClα or -β virus (serotypes 2, 5,
8; 1-10 × 1012 particles/ml in PBS) into CE (see above). Four weeks after surgery, on day 1,
animals were habituated 20 min to context A and given single i. p. dose of 1 % IVM
injectable solution (Phoenix) at 10 mg/kg BW, or vehicle. On day 2, animals were fear
conditioned in context A connected to a shock scrambler (Coulbourn Instruments,
Allentown, PA; Med Associates, St. Albans, VT). After 20 min mice were exposed to
training trials of 85 dBA 2 kHz 20 s tone immediately followed by a 2 sec 0.5 mA foot
shock with 198 sec inter-trial interval (ITI). To avoid masking of the consequences of the
experimental manipulation by ceiling and floor effects, the number of training trials (3-6)
was adjusted such that freezing levels averaged around 50 % in the genetic/viral control.
During the training session, behavior was recorded with infrared sensors (Coulbourn
Scientific) or video cameras (Med Associates). On day 3, mice were placed in context B,
differentiated from context A by a modified wall, floor and ceiling. Before each trial, all
surfaces were cleaned with water and disinfectant. After a 5 min baseline period, two test
trials of a 30 s CS followed by a 1 min post-CS period were presented. Freezing was scored
either manually by an observer blind to the experimental group of the animal (Coulbourn
Scientific), or electronically (Med Associates). Freezing during the CS and post-CS periods
are represented as bins of these two test trials. Baseline freezing was averaged over 3 min
before the first CS presentation.
To investigate the relationship between freezing and the extent of viral infection (Fig. S5, a-
c), freezing data were correlated with the fraction of PKCδ+ expressing GluClβ, estimated
as described above using native fluorescence for YFP and the standard curve in Fig. S7.
To investigate differences in freezing between experimental and control groups, freezing in
the experimental group was compared to genetic/viral control groups by 2-way ANOVA
with infection rate as blocking variable (Table S5, Fig. S5, d-f).
Retrograde tracing with CTB
CTB (0.5 % in PBS; List) was delivered by stereotaxic (see above) iontophoresis with a
positive-pulsed current of 5 μA for 2 min. The animals were sacrificed one week post-
injection, and the brains were processed for IHC.
Optogenetic circuit dissection
Mice were unilaterally injected with a total of 2 μl or Cre-dependent AAV ChR2 virus
(serotypes 2, 5; 1-10 × 1012 particles/ml in PBS) into CE (see above). Slices (see above)
were stimulated with an optic fiber (200 μm core diameter, ThorLabs), coupled to a 473 nm
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laser (CrystaLaser) and mounted on a 3-D micromanipulator (MPC365, Sutter) with the
fiber end positioned on the edge of CEl.
Cre-dependent monosynaptic tracing with Rabies virus
Cre-expressing cells were primed for subsequent infection and monosynaptic retrograde
spread of EnvA-pseudotyped, glycoprotein gene-deleted rabies virus, by stereotaxic
injection (see above) of 180 nl of Cre-dependent AAV expressing the avian receptor protein
TVA and rabies B19 glycoprotein (AAV9-pEF1α-FLEX-GTB) into CE. The genomic
structure of AAV9-pEF1α-FLEX-GTB is: L_ITR-EF1α Pro-Kozak-(FLEX cassette46
containing GFP-T2A-hTVA-E2A-hB19G)-STOP-WPRE-polyA-R_ITR. The start ATG has
been deleted from all three genes, and transcription start is mediated by a Kozak sequence
that precedes the FLEX cassette 47. Genes were linked together through the use of 2A
elements, which allow for the expression of multiple genes under the control of a single
promoter48,49. Both the TVA and B19G genes were codon-optimized for expression in
mammalian cells. The virus was prepared through a crude lysate extraction of transfected
293T cells, and has a genomic titer of 108 particles/ml. Although reverse-complemented
GFP is detectable in the AAV genome, Cre-expressing cells expressed undetectable levels of
GFP, either through native fluorescence or antibody-amplified imaging, while TVA and
B19G appear to express normally.
Three weeks later, mice were injected at the same site with 180 nL of glycoprotein gene-
deleted rabies virus 50 that has been pseudotyped with the avian sarcoma leucosis virus
glycoprotein EnvA 38. The glycoprotein gene has been replaced with mCherry. The resulting
virus, (EnvA)SAD-dG-mCherry, is incapable of infecting mammalian neurons in the
absence of its binding partner, TVA, and cannot spread retrogradely in the absence of the
rabies B19 glycoprotein 37. The biological titer of 109 particles/ml was determined through
infection of TVA-expressing 293T cells. One week after the second injection, the animals
were sacrificed and the brains processed for IHC.
Pharmacogenetic silencing with in vivo electrophysiological recordings
Mice were injected bilaterally with a total of 2 μl AAV GluClα virus (serotypes 2; 1-10 ×
1012 particles/ml in PBS) into CE (see above). Four weeks later, on day 1, mice were
habituated to 4 CS presentations (total CS duration of 30 s, consisting of 50-ms pips
repeated at 0.9 Hz, 2-ms rise and fall; pip frequency: 7.5 kHz, 80 dB sound pressure level) in
context B. On day 2, mice were conditioned with 5 CS/US (0.6 mA, 1 s) pairings with ITIs
of 20-180 s in context A (Coulbourn). On days 3, 6, 8, mice were exposed to 4 CS
presentations in context B. During these periods, individual neurons were recorded
extracellularly in freely behaving mice. Spikes of individual neurons were sorted by time-
amplitude window discrimination and template matching as previously described51,52.
Cluster quality was verified by quantifying the cluster separation52 (Fig. S8). Unit isolation
was verified using auto- and cross-correlation histograms. Spike rasters and histograms were
constructed by aligning sweeps relative to the CS onset, and CS-evoked responses were
normalized to baseline activity using a z-score transformation. Detailed methodological
information about in vivo single unit recordings of CE neurons is presented in Ciocchi et al..
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Characterization of CEl PKCδ+neurons
a, In situ hybridization (ISH) for PKCδ mRNA. CA3, hippocampus; Thal, thalamus. Boxed
area at higher magnification on right. b-j, Double-label fluorescence ISH (dFISH) for PKCδ
mRNA and the indicated markers. Insets, boxed areas. Filled and open arrowheads indicate
doubly vs. singly labeled cells, respectively. k-l, Whole-cell patch clamp recordings in acute
amygdala slices. Voltage changes (red) produced by respective current injections (black) are
illustrated. Resting membrane potentials were adjusted to ∼ -65 mV. m, n, Neurobiotin-
filled CEl neurons recorded in (k, l) after fluorescent streptavidin labeling and
immunostaining for PKCδ. o, Stimulus-response (I/O) curves for neurons based on
electrophysiological profile (late-firing, n = 22; regular spiking, n = 14), or PKCδ
expression (PKCδ+, n = 14; PKCδ-, n = 12) in CEl. See also Tables S2-S4.
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Figure 2. Transgenic targeting of PKCδ+neurons
a, Design of PKCδ∷GluClα−CFP-iCre BAC transgene. b-d, f-h, j-l, Expression of
transgene visualized by double-label immunofluorescent labeling (dIFL) for GFP and the
indicated markers. i, m, Quantification of f-h and j-l, respectively. Values are mean ± SEM,
n = 3. (e) X-gal staining of PKCδ∷GluClα-iCre; Rosa∷loxP-STOP-loxP-lacZ mice reveals
β-galactosidase expression (blue) in correct locations. Scale bar in b applies to c-h and j-l.
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Figure 3. CEl PKCδ+neurons directly inhibit CEm output neurons
a-j, Anterograde axonal tracing using Cre-dependent hrGFP AAV29. k-o, Retrograde tracing
from CEm using red fluorescent CTB. Scale bars for b-j, l-m, respectively. p-w,
Optogenetic activation of CEl PKCδ+ neurons inhibits PAG projecting neurons in CEm. p,
Schematic illustrating double-injection/slice recording experiments. q, CTB+ CEm cell
(CTB, arrowhead) with patch electrode (IR DIC, dashed lines) is illustrated. r-v, Whole-cell
voltage-clamp (Vhold = -40 mV) (r, s) or current clamp (t-v) recordings from a back-labeled
CEm neuron. r,s, IPSC triggered by a 2 ms 473 nm laser pulse, with (s) or without (r) 100
μM picrotoxin. t-v, suppression of depolarizing current injection-evoked spiking by 473 nm
laser pulses (2 ms, 15 Hz), with (u) or without (t) 100 μM picrotoxin. v, w, Quantification
of data in t (n = 5 cells; * P < 0.001, t-test) and v (n = 3 cells; P = 0.75, t-test), respectively.
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Figure 4. PKCδ+and PKCδ- make reciprocal inhibitory connections in CEl
a, Schematic and micrograph from slice preparation. Arrowhead indicates PKCδ(CFP)minus;
(YFP)- recorded cell in CEl. b-e, Whole-cell voltage clamp (Vhold = -40 mV) (b, c) or
current clamp (d, e) recordings from PKCδ- CEl neuron showing light-triggered (d),
picrotoxin-sensitive (c) IPSC, or picrotoxin-sensitive (e) suppression of depolarizing current
injection-evoked spiking (d) by ChR2 activation (blue dots; 2 ms, 15 Hz). f, g,
Quantification of data in d (f; n = 5 cells, *** P < 0.001, t-test) and e (g; n = 3 cells, P =
0.66, t-test), respectively. h, Schematic illustrating cell-specific Rabies virus infection. i-p,
immunostaining for PKCδ(i,m), intrinsic mCherry fluorescence (j, n) and nuclear staining
with TOPRO-3 (k, o) 3 days after RVΔG injection of transgenic (m-p) and wild-type (i-l)
mice. Primary infected PKCδ+ neurons (m, n insets, open arrowheads) and retrogradely
labeled PKCδ- cells (m, n insets, filled arrowheads) are indicated. q-t, Triple labeling for
PKCδ (q) and GABA (s) and mCherry (r). mCherry-labeled PKCδ- cells are GABAergic
(inset, arrowhead). Scale bars for f-m, n-q.
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Figure 5. IVM/GluCl-mediated suppression of CEl PKCδ+neuronal activity
a, Strategy for selective expression of GluClαβ in CEl PKCδ+ neurons. Yellow, CMV-
driven AAV∷GluClβ virus; blue, PKCδ∷GluClα-CFP transgene expression. b, Summary of
inhibitory connections in CEA (see also Ciocchi et al16). c-e, Current injection (bottom
trace)-evoked spiking (top, black trace) is suppressed by 20 nM IVM (middle, red trace) in
PKCδ+ cells expressing GluClαβ (c), but not in cells expressing either GluClβ-YFP (d) or
GluClα-CFP (e). f-h, Quantification of results in c-e, respectively (f, n = 4 cells, P = 0.005);
g, n = 5 cells, P = 0.73; h, n = 4 cells, P = 0.66; paired t-tests). i-n, IVM/GluCl-mediated
silencing of PKCδ+ neurons during chronic in vivo recording. i, Behavioral data for mice
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used in recording experiments. Hab, habituation; FC, fear conditioning. (n = 5) j, Coronal
schematic showing recording sites in CEl and CEm (-1.34 mm posterior to bregma). BLA:
basolateral amygdala. k, l Representative raster plots (upper) and normalized population
peristimulus time histograms (lower) of CEloff (k; lower, n = 6 neurons from 3 mice) and
CElon neurons (l; lower, n = 10 neurons from 4 mice) (P < 0.05). Confirmation of unit
isolation is shown in Figure S11. m, Tonic activity of CEloff neurons (One-way ANOVA
(F(2,15) = 4.845, P = 0.024) with post-hoc Bonferroni t-test (* P < 0.05), but not of CElon
neurons (One-way ANOVA (F(2,27) = 0.391, P = 0.680)), is significantly (Day 6) and
reversibly (Day 8) reduced by IVM (10 mg/kg, i.p.), while tonic activity of CEm neurons is
increased (n = 5 units from 1 mouse; one-way Kruskal-Wallis ANOVA (H = 7.487, with 2
degrees of freedom, P = 0.024) with post-hoc Tukey's HSD (* P < 0.05)). n, Specificity
controls for (m). IVM injection without virus infection (n = 3; P = 0.765); vehicle (DMSO)
injection with AAV2∷GluClβ virus infection (n =5; P = 0.940). CElon neurons (n = 10; P =
0.497); CS-non responsive neurons (n = 9; P = 0.644). *P < 0.05 (paired t-tests with vs.
without IVM in virus-injected mice).
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Table I
Behavioral effect of silencing PKCδ+ neurons in CEl
Group (Block 9) Inf. Ratea (%) BL Freezing (%) CS Freezing (%) Post-CS freezing (%)
Control (GluClα or GluClβ + IVM) 40.0±0.8 5.8±2.2 49.4±10.4 19.2±6.0
Experimental (GluClαβ +IVM) 40.6±3.5 2.6±1.5 (n. s.) 91.1±4.7 (P < .05) 75.3±8.4 (P < .001)
The data are derived from the Randomized Block ANOVA in Table S5 (total n=108; 6 experimental and 6 control animals assigned to each of 9
blocks), and illustrate the block with the highest level of viral infection in CEl (aInfection Rate, % of PKCδ+ cells expressing GluClβ-YFP; see
Fig. S10). The control group is pooled (Fig. S4b) single subunit-expressing mice (GluClα or GluClβalone) treated with IVM. Values represent the
mean±S.E.M. n.s., not significantly different. P values are from post-hoc Bonferroni t-test. A significant linear component to the block × group
interaction indicated that the difference between groups tended to increase with infection rate (F(1,90) = 22.98, P < 0.0001 for CS, F(1, 90) = 8.85,
P < 0.006 for post-CS). See also Table S5 and Figure S5. Control GluClαβ-expressing mice not treated with IVM were significantly different from
the experimental group among animals exhibiting bilateral AAV infection above the median rate (n=6-21; Fig. S7).
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